USANA Health Sciences Insider Receives RSU Shares, No Sales Filed
Rhea-AI Filing Summary
USANA Health Sciences (USNA) – Form 4 filing: Director Gilbert A. Fuller reported the first vesting tranche of a previously granted restricted-stock-unit (RSU) award.
- Transaction date: 24 Jul 2025
- Type (Code M): automatic conversion of RSUs into common shares
- Shares acquired: 1,058 common shares at $0 cost
- Post-transaction ownership: 1,058 common shares held directly and 3,172 RSUs still outstanding
- Vesting schedule of remaining RSUs: 25 % on 23 Oct 2025, 22 Jan 2026, and 23 Apr 2026
The filing reflects routine equity-based compensation; no shares were sold and no cash proceeds were involved. The transaction is unlikely to materially affect the company’s share float or signal a directional view beyond normal incentive alignment.
Positive
- Director increased direct equity stake by 1,058 shares, modestly aligning insider incentives with shareholders.
Negative
- None.
Insights
TL;DR: Director merely received 1,058 shares from RSU vesting; no buy/sell, negligible float impact.
The Code M conversion is a non-open-market event and therefore neutral for supply/demand dynamics. Fuller still holds 3,172 unvested RSUs, indicating continued alignment with long-term performance. Absence of share disposal suggests no negative insider sentiment. For a company with ~19 M shares outstanding, 1,058 shares (≈0.006 %) have no valuation significance. Overall, the disclosure is routine and non-impactful.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,058 | $0.00 | -- |
| Exercise | Common Stock | 1,058 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.